INS and metabolic disease: The homeostasis model assessment of insulin resistance (HOMA-IR) is a widely utilized method for assessing insulin resistance in both epidemiological studies and clinical settings, offering a reliable estimate of insulin sensitivity based on fasting glucose and insulin levels.[5] Recent studies have highlighted the role of various serum biomarkers in the development of insulin resistance and related metabolic disorders.